Subscribe
Subscribe today to receive CGD’s latest newsletters and topic updates.
All Commentary
Filters:
Topics
Facet Toggle
Content Type
Facet Toggle
Blog Type
Facet Toggle
Time Frame
Facet Toggle
Blog Post
July 31, 2020
Accurately forecasting the demand for health products at health clinics, and ordering the correct quantity, is a significant challenge to ensuring availability of health products at the last mile of health systems. While much progress has been made since then in terms of more accurate global fo...
Blog Post
July 29, 2020
Effective and efficient procurement of health products—medicines, diagnostics, and devices—is a critical function of all strong health systems. The pandemic has exacerbated long-standing challenges—as highlighted by a recent CGD Working Group—in the purchasing of both COVID-related emergency supplie...
Blog Post
July 23, 2020
As vaccines complete the different phases of development (pre-clinical, phase I, phase II, phase III, regulatory review, and license), results will be published in the scientific literature and announced to the public through the media and press releases. We our currently working as part of a larger...
Blog Post
July 22, 2020
Policy forged at pace and during extreme circumstances will often leave something wanting. We want more resilient supply chains, but we shouldn’t sacrifice the benefits that existing supply chains have created, nor should we needlessly penalize developing countries in the race for resilience.
Blog Post
June 09, 2020
Around the world COVID-19 and the policy responses to it are causing unprecedented disruptions of life and wellbeing. As scientists and governments around the world race to develop a vaccine at scale, we take a look at what a portfolio approach entails and why it is so important.